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Available online 18 May 2016Background: Coronary computed tomography angiography (CCTA) is obtained using peripheral intravenous
iodinated contrast agents (ICA) injection. There is continuing attempts to derive coronary physiological informa-
tion like coronary blood ﬂow (CBF) and/or fractional ﬂow reserve from CCTA images. However, no data is avail-
able regarding the effect of peripheral intravenous injection of ICA on CBF.
Methods: A series of 4 experiments was performed using healthy mongrel dogs. All dogs underwent anesthesia
and open thoracotomy with placement of ultrasound ﬂowmeter to one of the coronary artery to provide real
time absolute CBF measurements. Different infusion protocols of Isovue-370 and Visipaque-320 were injected
into a peripheral vein. Similar doses of normal saline injection were performed to be used as controls. The effect
of iodinated contrast media injection on absolute coronary blood ﬂow was monitored and recorded.
Results: Injection of normal saline in the peripheral vein did not produce any signiﬁcant increase in CBF. Periph-
eral intravenous injection of ICA resulted in a consistent increase of 40–73% in absolute CBF as recorded 5minutes
post-contrast administration. The contrast effect starts about 30 seconds and peaks at about 2 minutepost-con-
trast injection then slowly fades away in the following 10–15min. The increase in the CBFwas dose related. There
was greater increase in the CBF to 50 ml infusion compared to 25 ml infusion of both Visipaque and Isovue.
Conclusions: Peripheral venous administration of iodinated contrast-media in dogs results in a dose related,
signiﬁcant and prolonged increase in CBF.
© 2016 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Intravenous1. Introduction
Iodinated contrast media are the cornerstone agents used for ra-
diographic vascular imaging. Coronary computed tomography (CT)
angiography (CTA) is a radiographic imaging study in which CT im-
ages of the coronary artery are obtained after an intravenous injec-
tion of a contrast agent to opacify the coronary arteries. Over the
past decade, Coronary CTA has been used increasingly for the diag-
nosis of coronary artery disease. This increased use has been the re-
sult of the signiﬁcant advances in the technology of the coronary
CTA including improving the spatial and temporal resolution and re-
ducing radiation dose.
While coronary CTA is primarily an imaging modality to deﬁne cor-
onary anatomy, there are continued efforts to derive physiological infor-
mation of the coronary circulation from coronary CTA images. Examplesis an open access article under the Cinclude myocardial CT perfusion (CTP) studies [1–4], fractional ﬂow
reserve (FFR) derived from coronary CT angiography (CTA) also
known as CT-FFR [5,6] and Transluminal Attenuation Gradient (TAG)
[7]. Our group recently described a newway to derive absolute coronary
ﬂow from coronary CTA images [8]. All those relatively new techniques
are attempts to extract information about the coronary blood ﬂow from
static CTA images that are acquired following peripheral intravenous in-
jection of iodinated-contrast.
Injection of iodinated contrast agents directly inside the coronary
arteries in dogs [9] and humans [10,11] causes vasodilation and in-
crease in coronary blood ﬂow. However, no data is available regard-
ing the effect of iodinated contrast agents on coronary blood ﬂow
when those agents are injected in the peripheral veins. This data is
critical in order to guide further efforts to improve attempts to derive
physiological information about the coronary artery from coronary
CTA images.
In this study, we describe the effect on peripheral injection of two
types of iodinated contrast media on absolute coronary blood ﬂow in
dogs.C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Shows graphical representation of the effect of different doses of intravenous
injection of Isovue and Visipaque on coronary ﬂow over time in the left circumﬂex
artery from dog experiment #4. X axis is time in seconds; Y axis is percentage change of
blood ﬂow compared to baseline.
Table 1
Effect of peripheral intravenous contrast injection on absolute coronary blood ﬂow in the ﬁrst 3 dog experiments.
Dog
number
Coronary
artery
Contrast
type
Contrast
dose
Coronary ﬂow (ml/min) at baseline
(pre-contrast infusion)
Coronary ﬂow (ml/min) at
5-minutepost-contrast infusion
Percentage increase in absolute
coronary blood ﬂow
1st LAD Isovue 25 mL @ 2.5 ml/s 26 45 73%
2nd LAD Isovue 25 mL @ 2.5 ml/s 28 40 42%
3rd LCx Visipaque 25 mL @ 2.5 ml/s 54 76 40%
LAD: left anterior descending; LCx: left circumﬂex.
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A series of 4 experiments was performed using healthy mongrel
dogs. All procedures were approved by the Johns Hopkins Animal Care
and Use Committee. Each dog weighed between 25 and 30 Kg. Each
dog fasted for 8 h prior to the study. These dog experiments were de-
signed primarily to investigate the effect of peripheral intravenous in-
jection of iodinated contrast agents on coronary blood ﬂow. A
secondary goal of the experiments was to correlate direct coronary
ﬂow measurement with a novel CT derived coronary blood ﬂow mea-
surement. Therefore, the ﬁrst 3 dog experiments contrast injections
were part of cardiac CT scanning protocol. However, the 4th dog exper-
iment contrast injections were not associated with cardiac CT scanning
to allow closer monitoring of contrast effect on coronary ﬂow.
Pre-anesthesia sedation was provided by 3 mg of Acepromazine in-
tramuscular injection. A peripheral IV was placed. The dogs were then
anesthetized and intubated in the usual aseptic manner. Propofol was
used for induction of anesthesia and Isoﬂuorane at 0.5–2% was used
for maintenance of anesthesia. Additionally, an 8 French sheath was
placed in the right femoral artery. A pressure sensorwas placed through
the sheath for continuous pressure monitoring of the descending aorta.
2.1. Open thoracotomy and epicardial coronary artery instrumentation
A left lateral thoracotomywas performedwith the dogpositioned on
the right side and ventilated mechanically. Following a blunt and sharp
dissection, the pericardiumwas exposed and incised. Further dissection
was performed to isolate a 5 cm segment of the proximal left anterior
descending artery (LAD) (ﬁrst and second dogs) or 5 cm segment of
the proximal left circumﬂex (LCX) artery (3rd and 4th dogs). The LCX
artery is usually double the size of the LAD and has twice the ﬂow of
the LAD. Once the LAD or the LCX was isolated, we placed an ultrasonic
ﬂow meter at the proximal part of the vessel for continuous coronary
blood ﬂow measurements.
2.2. Contrast agents
Visipaque 320 (Iodixanol) is a dimeric, isosmolar, nonionic, water-
soluble, radiographic contrast medium with a molecular weight of
1550.20 g/mo. It has an osmolality of 290 mOsm/Kg water and iodine
content of 320 mgI/ml. It is made by GE Healthcare.
Isovue 370 is a monomer, hyperosmolar, nonionic, water-soluble
contrast medium with a molecular weight of 777.08 g/mo. It has an
osmolality of 796 mOsm/Kg water and iodine content 370 mgI/ml. It is
developed by Bracco Imaging, S.p.A.
2.3. Contrast injection protocol
The ﬁrst 3 dog experiments were performed with the infusion of
25 ml of contrast at a rate of 2.5 ml/s. Isovue was used in the ﬁrst and
second experiment while Visipaque was used in the third. For the ﬁrst
and second dog experiments, the coronary ﬂow values were recorded
before and 5-min after contrast administration.
In the 3rd dog experiment, coronary ﬂow values were also recorded
before and 5-min after contrast administration. However, two addition-
al Visipaque 25 ml injections at a rate of 2.5 ml/s at about 10-minuteintervals were given in order to examine the additive effect of multiple
contrast injections on coronary blood ﬂow. Coronary blood ﬂow mea-
surements were recorded continuously as well as before and after
each injection.
For the 4th dog experiment, we sequentially infused different doses
of Isovue, Visipaque and normal saline. At each injection we recorded
baseline coronary ﬂow and post-contrast injection coronary ﬂow
every 30 s until the coronary ﬂow returned to the pre-injection baseline
value. We used two contrast doses: 25 ml at 2.5 ml/s and 50 ml at
2.5 ml/s. We repeated the experiment sequentially using Isovue,
Visipaque and normal saline. Normal saline was used as a control. The
effect of each contrast injection protocol on coronary ﬂowwas graphed
across time. The magnitude of coronary ﬂow change was indexed per
baseline ﬂow and compared to different contrast injection protocols.
3. Results
Injection of normal saline in the peripheral vein did not produce any
signiﬁcant increase in the coronary blood ﬂow. In the ﬁrst 3 dog exper-
iments, peripheral intravenous injection of contrast (Visipaque or
Isovue) resulted in a consistent increase of 40–73% in absolute coronary
blood ﬂow as recorded 5minute post-contrast administration (Table 1).
The 4th dog experiments revealed that the contrast effect starts about
30 s and peak at about 2 minutepost-contrast injection then slowly
fades away in the following 10–15min. (Fig. 1). The increase in the cor-
onary blood ﬂow in response to peripheral contrast injection was dose
related. There was greater increase in the coronary blood ﬂow to
50ml infusion compared to 25ml infusion of both Visipaque and Isovue
(Fig. 1). Furthermore, multiple consecutive injections of contrast result-
ed in additive effects resulting in 133% increase in the absolute coronary
ﬂow for Visipaque and 100% for Isovue. (Figs. 2 and 3).
4. Discussion
In this study, we examined the effect of intravenous administration
of iodinated contrast media (Isovue and Visipaque) into a peripheral
vein on the coronary blood ﬂow in dogs. The study shows that there is
a signiﬁcant increase of moderate intensity (40–73%) in coronary
Fig. 2. Left circumﬂex blood ﬂow in dog #3 in response to every 10 min of intravenous
injection of 25 cm3 of Visipaque for a total of 3 injections. X axis in minutes. Y axis is
ﬂow in ml/min. There is a cumulative increase in coronary ﬂow with multiple sequential
injection of contrast. X axis is time in minutes with zero time is the time of the ﬁrst
scan. Y axis is the ﬂow as detected by the ultrasound ﬂowmeter measured in ml/min.
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the response appears to be dose related and cumulative with repeated
contrast injections increasing coronary blood ﬂow up to 133% of
baseline.
Iodinated contrast media is known to cause vasodilation and
increase in coronary blood ﬂow after a direct intra-arterial injection in
both human [10,11] and dogs [9]. Narishige et al. study found a dose re-
sponse increase in coronary ﬂow to 50% with 1 ml and 80% with 3 ml
intracoronary injection of Iopamidol (Isovue) and Iomeprol, respective-
ly. The positive effect of contrast media on coronary ﬂow in Harishige
study was short and lasted for about 1.5 min. Steiner RM et al. found a
60% increase in femoral artery blood ﬂow following an intra-arterial in-
jection of Iopamidol (Isovue) compared to about 100% increase with
Conray (Iothalamate) 280 contrast agent in dogs. The effect of
Iopamidol peaked at 30 secondpost-injection and faded slowly over
2 minutepost-injection [12].
Our study ﬁndings are consistent with prior literature. The magni-
tude of increase of coronary ﬂow was dependent on the dose and type
of contrastmedia used and overall rangedbetween 40 and 73%after sin-
gle injection. However, multiple cumulative injections of Isovue and
Visipaque caused much more robust increase in coronary ﬂow up to
100% for Visipaque and 133% for Isovue. Even more striking is that the
duration of the contrast-induced hyperemic response is much larger
than what has been reported in the literature. As seen in Fig. 1, a hyper-
emic response lasted for about 12 min after 25 ml of Isovue and
Visipaque injection, while a 50 ml of injection of Isovue had an effectFig. 3. Left circumﬂex blood ﬂow in dog #4 in response to every 5 minute injection of
25 cm3 of Isovue for a total of 3 injections. There is a cumulative positive response of
increased blood ﬂow with each injection. X axis is time in minutes. Y axis is absolute
coronary ﬂow in the LCx artery.that last to 22 min before coronary ﬂow returned to baseline. Such a
prolonged effect of contrast induced hyperemic response in our study
is likely because of the relatively large bolus of contrast (about 1 cm3/kg
per dog weight) and possible recirculation of the contrast media in the
blood system exposing the coronary vasculature to a longer period of
contrast compared to a small intra coronary injection.
To our knowledge this is the ﬁrst study to report on the effect of in-
travenous iodinated contrast injections on coronary blood ﬂow in dogs.
Prior studies looked only at the effect of direct intra-arterial (not intra-
venous) contrast injection on coronary diameter and ﬂow which is rel-
evant to invasive coronary angiography. They showed amild increase in
coronary diameter and ﬂow in response to direct intracoronary injec-
tion [10,13,14].
Themechanism bywhich iodinated contrast media increases vascu-
lar blood ﬂow has been described and is thought to be related to vaso-
dilation. The exact mechanism that underlies contrast agent-induced
vasodilation remains to be fully elucidated, but it is thought to be the
result of direct action on the vascular smoothmuscle that involvesmod-
ulation of Na+/K+ ATPase, intracellular Ca+2 sequestration and/or
Na+/H+ exchange [15,16].
The rapidly expanding use of coronary CTA in which contrast en-
hanced images of the coronary arteries are obtained after an iodinated
contrast media is injected through a peripheral vein calls for further un-
derstanding of the interaction of the intravenous contrast agent with
the coronary ﬂow. The arrival of the contrast agent to the coronary cir-
culation is likely to cause changes to the coronary vascular tree, yet the
nature of these changes and their impacts on cardiac CT images have not
been described before, whether in dogs or humans. The effect of intra-
venous injection of iodinated contrast agents on coronary ﬂow is even
more critical in myocardial CT perfusion (CTP) studies. In myocardial
CTP studies, achieving maximal hyperemia is essential in producing a
diagnostic quality studies. Usually, this is achieved by using adenosine
or dipyridamole infusion which is usually time consuming and requires
special nursing skills. Further understanding of the contrast agent's hy-
peremic effects might help simplify the myocardial CTP protocols by
getting rid of the need for adenosine or dipyridamole infusion as a result
of optimizing the hyperemic response of the contrast agent.
5. Conclusion
Peripheral venous administration of iodinated contrast-media in
dogs results in a dose related, signiﬁcant and prolonged increase in cor-
onary blood ﬂow. Larger studies are needed to conﬁrm these ﬁndings
and evaluate if a similar effect is present in humans.
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